Company intelligence / Profile preview
ForagR Medicines
Carrboro, North Carolina, USAforagrmed.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ForagR Medicines is an early-stage biotech company founded in 2024 that develops small-molecule drugs targeting disease-associated RNAs using a proprietary transcriptome-wide RNA-ligand discovery platform. The company aims to address hard-to-treat diseases by making previously "undruggable" targets accessible through innovative chemistry and genomics approaches. It has received NSF SBIR Phase I funding to advance its technology but has not yet reached clinical trials or disclosed specific lead programs or results.
- Therapeutic areas
- Other
- Modalities
- Small moleculeRNA-targeted small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
BASF Corporation collaboration for applying the platform to crop protection/insecticides during academic phase—not clear if ongoing at corporate level.No major pharma/biotech partnerships announced as of June 2025.
Beyond the preview
Go deeper on ForagR Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ForagR Medicines.